Brunico Hospital (SABES - ASDAA)
- Address
- Spitalstrasse 11, 39031 Bruneck, Italy
Brunico Hospital (SABES - ASDAA) - Rheumatology Research Center
Brunico Hospital, part of the SABES-ASDAA healthcare system, is actively engaged in clinical research focused on rheumatologic conditions. The center participates in advanced Phase III multi-center trials investigating innovative therapeutic approaches for inflammatory rheumatic diseases, with particular emphasis on improving patient outcomes while minimizing long-term glucocorticoid exposure.
- Polymyalgia Rheumatica treatment optimization and glucocorticoid-sparing strategies
- JAK inhibitor therapies for inflammatory rheumatic conditions
- Novel remission-induction regimens for autoimmune disorders
The research team specializes in evaluating disease-modifying therapies that can achieve sustained remission while reducing the burden of traditional treatments. Their involvement in pivotal trials demonstrates expertise in managing polymyalgia rheumatica, a common inflammatory condition affecting older adults, and investigating Baricitinib as a potential glucocorticoid-sparing agent to improve long-term safety profiles for patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Brunico Hospital (SABES - ASDAA)
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Arthritis interception with Guselkumab in subclinical psoriatic arthritis patients in clinical transition from skin to joint disease: a randomized clinical trial. | Azienda Sanitaria Universitaria Friuli Centrale | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Baricitinib | 1 | Unknown | 2022-05-10 | 2022-05-10 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.